Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/18: Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/18: Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Patent # | Title | Filing Date | Issue Date | Patent Owner |
---|---|---|---|---|
11957699 | Composition comprising punicalagin for inhibiting PAR2 activity | Jul 30, 19 | Apr 16, 24 | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
11959108 | Engineered protease variants | Aug 27, 21 | Apr 16, 24 | Codexis Inc.; Societe des Produits Nestle SA; |
11938172 | Method for regulating and controlling GLP-1/GLP-1R and drug | Jun 19, 18 | Mar 26, 24 | TALENGEN INTERNATIONAL LIMITED |
11918553 | Anti-oncogenic phytochemicals comprising substituted henicosanoic acid and henicosenoic acid | Jun 16, 23 | Mar 05, 24 | Ostentus Therapeutics, Inc. |
11834499 | Claudin18 antibodies and methods of treating cancer | Oct 03, 22 | Dec 05, 23 | The Regents of the University of California |
11771735 | Composition for improving or preventing nonalcoholic fatty liver | Nov 19, 21 | Oct 03, 23 | KOHJIN LIFE SCIENCES CO., LTD.; PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY; KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION; President of Saga University; |
11767519 | Engineered amylase variants | Aug 27, 21 | Sep 26, 23 | Codexis Inc.; Societe des Produits Nestle SA; |
11758928 | Compositions and methods that modulate phosphorus or enzymes in a companion animal | Dec 12, 17 | Sep 19, 23 | Société des Produits Nestlé S.A. |
11752106 | Pharmaceutical composition and administrations thereof | Sep 15, 21 | Sep 12, 23 | Vertex Pharmaceuticals Incorporated |
11752148 | Pyrazine-containing compound | Mar 16, 21 | Sep 12, 23 | CALCIMEDICA INC. |
11744868 | dextran, preparation method and application thereof | Feb 08, 23 | Sep 05, 23 | JILIN AGRICULTURAL UNIVERSITY |
11737972 | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | Oct 12, 22 | Aug 29, 23 | CritiTech Inc. |
11737983 | Storage stable sincalide formulations | Apr 01, 22 | Aug 29, 23 | MAIA Pharmaceuticals, Inc. |
11725043 | Ulinastatin polypeptides | Mar 05, 21 | Aug 15, 23 | DiaMedica USA Inc. |
11691945 | USP9X inhibitors | Nov 16, 22 | Jul 04, 23 | ProDeg, LLC |
11628206 | Method for inhibiting STAT3 activity comprising administering Ssu72 | Jan 21, 21 | Apr 18, 23 | CUROGEN TECHNOLOGY CO., LTD. |
11578309 | Universal donor cells | Dec 31, 21 | Feb 14, 23 | CRISPR Therapeutics AG |
11566230 | Universal donor cells | Dec 31, 21 | Jan 31, 23 | CRISPR Therapeutics AG |
11547745 | Compositions and methods for treating pancreatic enzyme deficiencies in mammals | Aug 23, 19 | Jan 10, 23 | Vets Plus, Inc. |
11534477 | Use of peptide compounds in treating acute pancreatitis | Sep 03, 20 | Dec 27, 22 | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. |
Publication # | Title | Filing Date | Pub Date | Patent Owner |
---|---|---|---|---|
2024/0182,406 | COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Mar 14, 22 | Jun 06, 24 | Not available |
2024/0174,690 | ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER | May 09, 23 | May 30, 24 | Not available |
2024/0150,423 | GLP-1 ANALOGUE-MODIFIED DIMERS WITH DIFFERENT CONFIGURATIONS, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN TREATMENT OF TYPE II DIABETES | Nov 09, 20 | May 09, 24 | Nanjing Finepeptide Biopharmaceutical Co.,Ltd |
2024/0139,337 | METHOD FOR TREATING A CANCER AND/OR CANCER METASTASIS | Nov 02, 22 | May 02, 24 | Not available |
2024/0041,980 | COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) | Aug 25, 23 | Feb 08, 24 | Not available |
2024/0026,326 | ENGINEERED AMYLASE VARIANTS | Sep 06, 23 | Jan 25, 24 | Not available |
2024/0009,163 | Anti-Oncogenic Phytochemicals and Methods and Uses for Treating Cancer | Jun 16, 23 | Jan 11, 24 | Ostentus Therapeutics, Inc. |
2023/0372,234 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles | Jul 13, 23 | Nov 23, 23 | Not available |
2023/0270,855 | Genetically Modified T-Cells and PI3K/AKT Inhibitors For Cancer Treatment | Apr 09, 19 | Aug 31, 23 | Not available |
2023/0241,000 | GSK3 INHIBITOR-LOADED NANO FORMULATIONS AS A CANCER IMMUNOTHERAPEUTIC | Jun 29, 21 | Aug 03, 23 | The Regents of the University of California |
2023/0210,782 | NON-PORCINE FORMULATIONS AND METHODS THEREOF | Jun 17, 21 | Jul 06, 23 | Not available |
2023/0210,849 | CADHERIN-11 INHIBITOR FORMULATION AND ITS USES IN IMMUNOTHERAPY | Jun 04, 21 | Jul 06, 23 | Georgetown University |
2023/0151,368 | EXTRACELLULAR VESICLE SECRETION REDUCING AGENT FOR REDUCING EXTRACELLULAR VESICLE SECRETION, AND USE OF THE SAME | Apr 07, 21 | May 18, 23 | Not available |
2022/0000,863 | PYRAZINE-CONTAINING COMPOUND | Sep 10, 21 | Jan 06, 22 | Not available |
2020/0345,867 | ORGAN DIRECTED GENE DELIVERY | Apr 30, 20 | Nov 05, 20 | Not available |
2019/0201,381 | COMPOSITIONS FOR CRYOPRESERVATION AND METHODS OF USE THEREOF | Dec 31, 18 | Jul 04, 19 | EVERGREEN BIOSCIENCES |
2019/0192,626 | TREATMENT OF LIVER, BILIARY TRACT AND PANCREATIC DISORDERS | Apr 28, 17 | Jun 27, 19 | DEFENSIN THERAPEUTICS APS |
2018/0140,681 | COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE, CONTAINING SSU72 AS ACTIVE INGREDIENT | Mar 31, 15 | May 24, 18 | The Catholic University of Korea Industry-Academic Cooperation Foundation |
2013/0039,897 | COMPOSITIONS AND METHODS FOR REGULATING NEUTROPHIL MOVEMENT AND NEUTROPHIL NUMBERS IN A BODY REGION | Aug 10, 12 | Feb 14, 13 | THE TEXAS A&M UNIVERSITY SYSTEM |
2012/0210,451 | ISLET CELL SHEET, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF | Aug 02, 10 | Aug 16, 12 | TOKYO WOMEN'S MEDICAL UNIVERSITY |
Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
---|